Suppr超能文献

癌组织中绿色自发荧光的降低是诊断肾细胞癌的一种潜在生物标志物。

Decreased green autofluorescence in cancerous tissues is a potential biomarker for diagnosis of renal cell carcinomas.

作者信息

Wan Wei, Zou Junrong, Xie Tianpeng, Zeng Liang, Liu Huiquan, Jiang Bo, Liao Yunfeng, Wu Yuting, Wu Gengqing, Zhang Guoxi, Ying Weihai, Zou Xiaofeng

机构信息

First Clinical Medical College, Gannan Medical University, Ganzhou, China.

Institute of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

出版信息

Sci Rep. 2025 Jul 23;15(1):26798. doi: 10.1038/s41598-025-12053-z.

Abstract

This study primarily focuses on the potential sources of autofluorescence, including keratins (KRT) encoded by KRT1, KRT7, and KRT8, to investigate their contributions to the differences in autofluorescence between cancerous tissues and adjacent non-tumor tissues, as well as their potential for real-time diagnosis of RCC. First, the autofluorescence of renal cell carcinoma (RCC) tissues under 488 nm laser excitation was observed and compared with the autofluorescence of neighboring non-tumor tissues. Then, the effect on the autofluorescence intensity was analyzed by knocking down the KRT1/KRT7 gene. In addition, autofluorescence data were collected from 174 pairs of tumor and adjacent non-tumor tissue samples (from 60 RCC patients). Diagnostic performance was evaluated using ROC analysis to determine the threshold value for tumor autofluorescence intensity. Under 488 nm laser excitation, the intensity of green autofluorescence in cancerous tissues of RCC patients was significantly lower than that in non-tumor tissues. Further analysis showed that KRT1 knockdown resulted in a 73% reduction in autofluorescence intensity, suggesting that KRT1 plays a key role in the reduced autofluorescence observed in tumor tissues. In addition, analysis of autofluorescence data from 174 tumor and adjacent non-tumor tissue samples showed an AUC of 0.880 for ROC analysis, a diagnostic sensitivity and specificity of 0.843 and 0.835, respectively, and a threshold value of 27.45 for using tumor autofluorescence intensity. KRT1 is a major contributor to the tumor autofluorescence observed in RCC. An autofluorescence-based diagnostic model facilitates real-time assessment of surgical margins during partial nephrectomy, thereby potentially improving surgical success rates.

摘要

本研究主要聚焦于自体荧光的潜在来源,包括由KRT1、KRT7和KRT8编码的角蛋白(KRT),以研究它们对癌组织与相邻非肿瘤组织之间自体荧光差异的贡献,以及它们在肾细胞癌实时诊断中的潜力。首先,观察了488nm激光激发下肾细胞癌(RCC)组织的自体荧光,并与相邻非肿瘤组织的自体荧光进行了比较。然后,通过敲低KRT1/KRT7基因分析其对自体荧光强度的影响。此外,从174对肿瘤和相邻非肿瘤组织样本(来自60例RCC患者)中收集了自体荧光数据。使用ROC分析评估诊断性能,以确定肿瘤自体荧光强度的阈值。在488nm激光激发下,RCC患者癌组织中绿色自体荧光强度显著低于非肿瘤组织。进一步分析表明,敲低KRT1导致自体荧光强度降低73%,表明KRT1在肿瘤组织中观察到的自体荧光降低中起关键作用。此外,对174个肿瘤和相邻非肿瘤组织样本的自体荧光数据进行分析,ROC分析的AUC为0.880,诊断敏感性和特异性分别为0.843和0.835,使用肿瘤自体荧光强度的阈值为27.45。KRT1是RCC中观察到的肿瘤自体荧光的主要贡献者。基于自体荧光的诊断模型有助于在部分肾切除术中实时评估手术切缘,从而有可能提高手术成功率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7729/12287290/c3f73753b56c/41598_2025_12053_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验